Primary results of EV-301: A phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial carcinoma Meeting Abstract


Authors: Powles, T.; Rosenberg, J. E.; Sonpavde, G.; Loriot, Y.; Duran, I.; Lee, J. L.; Matsubara, N.; Vulsteke, C.; Wu, C.; Campbell, M. S.; Matsangou, M.; Petrylak, D. P.
Abstract Title: Primary results of EV-301: A phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial carcinoma
Meeting Title: 2021 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 6 Suppl.
Meeting Dates: 2021 Feb 11-13
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-02-20
Language: English
ACCESSION: WOS:000636801500396
DOI: 10.1200/JCO.2021.39.6_suppl.393
PROVIDER: wos
Notes: Meeting Abstract: 393 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg